New Inflammatory Bowel Disease Study Results from Medical University of Lodz Described (Clinical Significance of Erythroferrone and Bone Morphogenetic Protein-6 in Patients with Anemia in the Course of Inflammatory Bowel Disease)

MLA

“New Inflammatory Bowel Disease Study Results from Medical University of Lodz Described (Clinical Significance of Erythroferrone and Bone Morphogenetic Protein-6 in Patients with Anemia in the Course of Inflammatory Bowel Disease).” Hematology Week, 2 Oct. 2023, p. 3265. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.767294103&authtype=sso&custid=ns315887.

APA

New Inflammatory Bowel Disease Study Results from Medical University of Lodz Described (Clinical Significance of Erythroferrone and Bone Morphogenetic Protein-6 in Patients with Anemia in the Course of Inflammatory Bowel Disease). (2023, October 2). Hematology Week, 3265.

Chicago

Hematology Week. 2023. “New Inflammatory Bowel Disease Study Results from Medical University of Lodz Described (Clinical Significance of Erythroferrone and Bone Morphogenetic Protein-6 in Patients with Anemia in the Course of Inflammatory Bowel Disease),” October 2. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.767294103&authtype=sso&custid=ns315887.